Looking out for eye health

Looking out for eye health By: Vicky Sanderson Canadians don’t pay enough attention to their vision. Consider that while 59 per cent may experience symptoms of eye disease, only 54 per cent of that number seek medical help, according to the...

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD Pre-specified analysis provides insight into maintenance treatment effectiveness with like-for-like comparison of...
On